⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30539244 | 1.00 | — | — | |
| SCHEMBL29257457 | 1.00 | — | — | |
| SCHEMBL31282752 | 1.00 | — | — | |
| SCHEMBL3955154 | 1.00 | — | — | |
| SCHEMBL182611 | 1.00 | — | — | |
| SCHEMBL25404147 | 1.00 | — | — | |
| SCHEMBL28888586 | 1.00 | — | — | |
| SCHEMBL3957856 | 1.00 | — | — | |
| SCHEMBL19649384 | 1.00 | — | — | |
| SCHEMBL27627588 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018187574-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS | CIDARA THERAPEUTICS, INC. (US) | 2018-10-11 | — | — | WO | claimed |
| WO-2018006063-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS | CIDARA THERAPEUTICS, INC. (US) | 2018-01-04 | — | — | WO | claimed |
| CN-105198954-A | C21 steroid compound in marsdenia tenacissima and preparation method and application thereof | NO 210 HOSPITAL PLA | 2015-12-30 | — | — | CN | claimed |
| EP-1222927-B1 | Pharmaceutical compositions having appetite suppressant activity | CSIR (ZA) | 2013-11-20 | — | — | EP | claimed |
| EP-1756140-B1 | SELECTIVE SEPARATION OR EXTRACTION OF STEROIDAL GLYCOSIDES BY SUPERCRITICAL FLUID EXTRACTION USING CARBON DIOXIDE | UNILEVER NV (NL) | 2011-03-09 | — | — | EP | claimed |
| EP-1213020-B1 | Compounds and pharmaceutical compositions having appetite suppressant activity | CSIR (ZA) | 2009-02-11 | — | — | EP | claimed |
| CN-101239090-A | Pharmaceutical composition with appetite suppressant activity | CSIR (ZA) | 2008-08-13 | — | — | CN | claimed |
| CN-101239089-A | Pharmaceutical composition with appetite suppressant activity | CSIR (ZA) | 2008-08-13 | — | — | CN | claimed |
| CN-100378118-C | Pharmaceutical composition with appetite suppressant activity | CSIR (ZA) | 2008-04-02 | — | — | CN | claimed |
| JP-3553086-B2 | — | — | 2004-08-11 | — | — | JP | claimed |
| EP-1222927-A2 | Pharmaceutical compositions having appetite suppressant activity | CSIR (ZA) | 2002-07-17 | — | — | EP | claimed |
| EP-1213020-A2 | Pharmaceutical compositions having appetite suppressant activity | CSIR (ZA) | 2002-06-12 | — | — | EP | claimed |
| US-6376657-B1 | STEROID TRISACCHARIDE EXTRACT OBTAINABLE FROM A PLANT OF THE GENUS TRICHOCAULON OR HOODIA | CSIR (ZA) | 2002-04-23 | — | — | US | claimed |
| JP-2000510482-A | — | — | 2000-08-15 | — | — | JP | claimed |
| CN-1252000-A | Pharmaceutical composition with appetite suppressant activity | CSIR (ZA) | 2000-05-03 | — | — | CN | claimed |
| EP-0973534-A1 | PHARMACEUTICAL COMPOSITIONS HAVING APPETITE SUPPRESSANT ACTIVITY | CSIR (ZA) | 2000-01-26 | — | — | EP | claimed |
| WO-1998046243-A2 | PHARMACEUTICAL COMPOSITIONS HAVING APPETITE SUPPRESSANT ACTIVITY | CSIR (ZA) | 1998-10-22 | — | — | WO | claimed |
| EP-0530224-A1 | NOVEL STEROID GLYCOSIDES USEFUL IN THE EARLY DETECTION OF HYPERTENSION | THE BOARD OF REGENTS OF THE UNIVERSITY OF WASHINGTON (US) | 1993-03-10 | — | — | EP | claimed |
| WO-1991017176-A2 | NOVEL STEROID GLYCOSIDES USEFUL IN THE EARLY DETECTION OF HYPERTENSION | THE BOARD OF REGENTS OF THE UNIVERSITY OF WASHINGTON (US) | 1991-11-14 | — | — | WO | claimed |
| US-3963697-A | Labelled cardiotonic glycosides for use in radioimmunoassay | CURTIS NUCLEAR CORPORATION (US) | 1976-06-15 | — | — | US | claimed |